Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
CHRS Coherus BioSciences
- 1.045
- -0.065-5.86%
Trading Apr 24 12:24 ET
121.11MMarket Cap4.18P/E (TTM)
1.110High1.020Low1.11MVolume1.090Open1.110Pre Close1.17MTurnover1.00%Turnover Ratio4.18P/E (Static)115.90MShares2.43052wk High-0.92P/B115.58MFloat Cap0.66052wk Low--Dividend TTM110.60MShs Float38.100Historical High--Div YieldTTM8.11%Amplitude0.660Historical Low1.054Avg Price1Lot Size
About Coherus BioSciences Company
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Company Profile
SymbolCHRS
Company NameCoherus BioSciences
Listing DateNov 6, 2014
Issue Price13.50
Founded2010
CEOMr. Dennis M. Lanfear
MarketNASDAQ
Employees228
Fiscal Year Ends12-31
Address333 Twin Dolphin Drive,Suite 600
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-649-3530
Websitehttp://www.coherus.com
Company Executives
- Name
- Position
- Salary
- Dennis M. Lanfear
- President, Chief Executive Officer and Chairman of the Board
- 5.90M
- Bryan J. McMichael
- Chief Financial Officer and Principal Accounting Officer
- 1.07M
- Paul Reider
- Chief Commercial Officer
- 1.93M
- Rita A. Karachun
- Director
- --
- Georgia L. Erbez
- Director
- --
- Dr. Michael Ryan, Pharm.D.
- Director
- 173.61K
- Mats L. Wahlstrom
- Lead Independent Director
- 228.69K
- Mark D. Stolper
- Independent Director
- 198.69K
- Charles Newton
- Independent Director
- 188.69K
- Ali J. Satvat
- Independent Director
- 65.00K
- Dr. Lee N. Newcomer, M.D.
- Independent Director
- 186.19K
- Dr. Jill O’Donnell-Tormey
- Independent Director
- 183.69K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
